Suppr超能文献

肠相关淋巴组织、T 细胞迁移和慢性肠道炎症。

Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation.

机构信息

Immunology and Inflammation Research Group, Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130, USA.

出版信息

Ann N Y Acad Sci. 2010 Oct;1207 Suppl 1(Suppl 1):E86-93. doi: 10.1111/j.1749-6632.2010.05711.x.

Abstract

The etiologies of the inflammatory bowel diseases (IBD; Crohn's disease, ulcerative colitis) have not been fully elucidated. However, there is very good evidence implicating T cell and T cell trafficking to the gut and its associated lymphoid tissue as important components in disease pathogenesis. The objective of this review is to provide an overview of the mechanisms involved in naive and effector T cell trafficking to the gut-associated lymphoid tissue (GALT; Peyer's patches, isolated lymphoid follicles), mesenteric lymph nodes and intestine in response to commensal enteric antigens under physiological conditions as well as during the induction of chronic gut inflammation. In addition, recent data suggests that the GALT may not be required for enteric antigen-driven intestinal inflammation in certain mouse models of IBD. These new data suggest a possible paradigm shift in our understanding of how and where naive T cells become activated to yield disease-producing effector cells.

摘要

炎症性肠病(IBD;克罗恩病、溃疡性结肠炎)的病因尚未完全阐明。然而,有充分的证据表明,T 细胞及其向肠道和相关淋巴组织的迁移是疾病发病机制中的重要组成部分。本篇综述的目的是概述在生理条件下以及在慢性肠道炎症的诱导下,针对共生肠内抗原,幼稚 T 细胞和效应 T 细胞向肠道相关淋巴组织(派尔集合淋巴结、孤立淋巴滤泡)、肠系膜淋巴结和肠道迁移的机制。此外,最近的数据表明,在某些 IBD 的小鼠模型中,GALT 可能不是肠内抗原驱动的肠道炎症所必需的。这些新数据表明,我们对幼稚 T 细胞如何以及在何处被激活产生致病效应细胞的理解可能会发生范式转变。

相似文献

1
Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation.
Ann N Y Acad Sci. 2010 Oct;1207 Suppl 1(Suppl 1):E86-93. doi: 10.1111/j.1749-6632.2010.05711.x.
2
Role of the gut-associated and secondary lymphoid tissue in the induction of chronic colitis.
Inflamm Bowel Dis. 2011 Jan;17(1):268-78. doi: 10.1002/ibd.21447. Epub 2010 Sep 1.
3
Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I).
Surgeon. 2003 Apr;1(2):63-75. doi: 10.1016/s1479-666x(03)80118-x.
4
Role of beta7 integrins in intestinal lymphocyte homing and retention.
Curr Mol Med. 2009 Sep;9(7):836-50. doi: 10.2174/156652409789105525.
6
The anatomy of mucosal immune responses.
Ann N Y Acad Sci. 2004 Dec;1029:9-15. doi: 10.1196/annals.1309.002.
8
Leukocyte Trafficking to the Small Intestine and Colon.
Gastroenterology. 2016 Feb;150(2):340-54. doi: 10.1053/j.gastro.2015.10.046. Epub 2015 Nov 6.
9
Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice.
J Exp Med. 1996 Aug 1;184(2):707-15. doi: 10.1084/jem.184.2.707.
10

引用本文的文献

1
Radiation-induced injury and the gut microbiota: insights from a microbial perspective.
Therap Adv Gastroenterol. 2025 Jun 16;18:17562848251347347. doi: 10.1177/17562848251347347. eCollection 2025.
2
Gut-brain-immune axis implications for mental health and disease.
Mol Cell Biochem. 2025 Jun 12. doi: 10.1007/s11010-025-05325-9.
3
Intestinal barrier damage caused by addictive substance use disorder.
Eur J Med Res. 2025 Apr 2;30(1):226. doi: 10.1186/s40001-025-02446-1.
4
Age-related alterations in gut homeostasis are microbiota dependent.
NPJ Biofilms Microbiomes. 2025 Mar 25;11(1):51. doi: 10.1038/s41522-025-00677-y.
7
Macrophage polarization in inflammatory bowel disease.
Cell Commun Signal. 2023 Dec 21;21(1):367. doi: 10.1186/s12964-023-01386-9.
8
Gut-lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy.
Front Oncol. 2023 Nov 22;13:1257515. doi: 10.3389/fonc.2023.1257515. eCollection 2023.
9
The microbiome landscape in pediatric Crohn's disease and therapeutic implications.
Gut Microbes. 2023 Dec;15(2):2247019. doi: 10.1080/19490976.2023.2247019.
10
The intestinal γδ T cells: functions in the gut and in the distant organs.
Front Immunol. 2023 Jun 16;14:1206299. doi: 10.3389/fimmu.2023.1206299. eCollection 2023.

本文引用的文献

1
Inflammatory bowel disease.
Annu Rev Immunol. 2010;28:573-621. doi: 10.1146/annurev-immunol-030409-101225.
2
Mechanisms maintaining peripheral tolerance.
Nat Immunol. 2010 Jan;11(1):21-7. doi: 10.1038/ni.1817. Epub 2009 Dec 17.
3
Inflammation in the intestinal tract: pathogenesis and treatment.
Dig Dis. 2009;27(4):455-64. doi: 10.1159/000235851. Epub 2009 Nov 4.
4
Biological therapies for inflammatory bowel diseases.
Gastroenterology. 2009 Apr;136(4):1182-97. doi: 10.1053/j.gastro.2009.02.001. Epub 2009 Feb 26.
5
T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade.
Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G135-46. doi: 10.1152/ajpgi.90462.2008. Epub 2008 Nov 25.
6
T-cell recruitment to the intestinal mucosa.
Trends Immunol. 2008 Nov;29(11):514-22. doi: 10.1016/j.it.2008.08.003.
7
Dendritic cells in intestinal immune regulation.
Nat Rev Immunol. 2008 Jun;8(6):435-46. doi: 10.1038/nri2335.
8
Homeostatic chemokines in development, plasticity, and functional organization of the intestinal immune system.
Semin Immunol. 2008 Jun;20(3):171-80. doi: 10.1016/j.smim.2008.03.001. Epub 2008 Apr 22.
9
Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids.
Inflamm Bowel Dis. 2008 Feb;14(2):275-89. doi: 10.1002/ibd.20280.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验